{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:30:29Z","timestamp":1793046629587,"version":"4.5.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic kidney disease (DKD) is one of the leading causes of end-stage kidney disease worldwide, and microbiota-based interventions are considered potential preventive and therapeutic strategies to slow its progression. This study evaluated the efficacy of probiotic supplementation in patients with DKD through a systematic review and meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched seven databases, including PubMed, Embase, the Cochrane Library (CENTRAL), CNKI, Wanfang, VIP and SinoMed, to identify all relevant studies published from database inception to July 2025. Eligible studies were randomized controlled trials assessing probiotic interventions in DKD patients. Study quality was evaluated using the Cochrane Risk of Bias tool, and meta-analyses were performed using R.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 11 studies involving 726 participants were included. Probiotic supplementation significantly improved serum creatinine (MD\u202f\u2212\u202f0.17, \u22120.22 to \u22120.12,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.0001) and estimated glomerular filtration rate (MD 9.62, 2.74 to 16.51,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.0001). No significant effects were observed for blood urea nitrogen, urinary albumin-to-creatinine ratio, 24-h urinary protein or cystatin C. Probiotics also showed notable benefits in glycemic and lipid parameters, including reductions in fasting plasma glucose (MD\u202f\u2212\u202f18.52, \u221227.08 to \u22129.97,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.0001), glycated hemoglobin (MD\u202f\u2212\u202f0.18, \u22120.31 to \u22120.05,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.009), and homeostasis model assessment of insulin resistance (MD\u202f\u2212\u202f1.22, \u22122.01 to \u22120.43,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.002), as well as an increase in high-density lipoprotein cholesterol (MD 5.45, 1.08 to 9.83,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.01). In addition, probiotic supplementation led to significant reductions in inflammatory and oxidative stress markers, including high-sensitivity C-reactive protein (MD\u202f\u2212\u202f1.53, \u22122.38 to \u22120.69,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.0004) and malondialdehyde (MD\u202f\u2212\u202f0.81, \u22120.97 to \u22120.65,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.0001), and a significant increase in total antioxidant capacity (MD 62.71, 41.80 to 83.62,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Probiotic supplementation may improve metabolic disturbances, renal function, and systemic inflammation\/oxidative stress in DKD patients. However, its clinical efficacy and long-term effects require further validation in large-scale studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2026.1760954","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:45:57Z","timestamp":1779255957000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of probiotic supplementation on diabetic kidney disease: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhi-Qing","family":"Huang","sequence":"first","affiliation":[{"name":"The First Clinical College, Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-Yu","family":"Li","sequence":"additional","affiliation":[{"name":"The First Clinical College, Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ting","family":"Li","sequence":"additional","affiliation":[{"name":"The First Clinical College, Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-Xin","family":"Zhang","sequence":"additional","affiliation":[{"name":"The First Clinical College, Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En","family":"Zhang","sequence":"additional","affiliation":[{"name":"Guangdong Clinical Research Academy of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Department of Nephrology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Lin","family":"Su","sequence":"additional","affiliation":[{"name":"Guangdong Clinical Research Academy of Chinese Medicine","place":["Guangzhou, China"]},{"name":"Department of Nephrology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"ref1","first-page":"36","article-title":"Kidney function improvement by soy milk containing Lactobacillus plantarum A7 in type 2 diabetic patients with nephropathy: a double-blinded randomized controlled trial","volume":"11","author":"Abbasi","year":"2017","journal-title":"Iran. J. Kidney Dis."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/cjn.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s12602-018-9468-x","article-title":"The effects of probiotic honey consumption on metabolic status in patients with diabetic nephropathy: a randomized, double-blind, controlled trial","volume":"11","author":"Arani","year":"2019","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41581-025-00988-5","article-title":"Microbiota and kidney disease: the road ahead","volume":"21","author":"Bloom","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00125-020-05295-1","article-title":"The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis","volume":"64","author":"Bock","year":"2021","journal-title":"Diabetologia"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1552358","DOI":"10.3389\/fnut.2025.1552358","article-title":"The impact of probiotics on oxidative stress and inflammatory markers in patients with diabetes: a meta-research of meta-analysis studies","volume":"12","author":"Chen","year":"2025","journal-title":"Front. Nutr."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"24169","DOI":"10.1021\/acs.jafc.5c07346","article-title":"Bifidobacterium longum subsp. longum B-53 alleviated abnormalities of glycolipid metabolism and oxidative stress in T2DM mice through regulating gut microbiota and GLP-1 secretion","volume":"73","author":"Chen","year":"2025","journal-title":"J. Agric. Food Chem."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/advances\/nmz028","article-title":"Gastrointestinal microbiota in patients with chronic kidney disease: a systematic review","volume":"10","author":"Chung","year":"2019","journal-title":"Adv. Nutr."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","article-title":"Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors","volume":"17","author":"DeFronzo","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"159234","DOI":"10.1016\/j.bbalip.2022.159234","article-title":"Empagliflozin ameliorates type 2 diabetes mellitus-related diabetic nephropathy via altering the gut microbiota","volume":"1867","author":"Deng","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-025-04412-3","article-title":"Efficacy and safety of probiotic\/synbiotic supplementation for overweight or obese children: a systematic review and meta-analysis of randomized controlled trials","author":"Ding","year":"2025","journal-title":"Pediatr. Res."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00281-021-00871-y","article-title":"The mucosal immune system and IgA nephropathy","volume":"43","author":"Gesualdo","year":"2021","journal-title":"Semin. Immunopathol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"8347","DOI":"10.1021\/acs.jafc.4c00263","article-title":"Exploring the preventive and therapeutic mechanisms of probiotics in chronic kidney disease through the gut-kidney Axis","volume":"72","author":"Huang","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e23650","DOI":"10.1002\/jcla.23650","article-title":"Probiotics ameliorates glycemic control of patients with diabetic nephropathy: a randomized clinical study","volume":"35","author":"Jiang","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"750","DOI":"10.7150\/ijbs.125140","article-title":"Microbiota-gut-kidney axis in health and renal disease","volume":"22","author":"Jin","year":"2026","journal-title":"Int. J. Biol. Sci."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11892-018-1064-7","article-title":"Metabolic abnormalities in diabetes and kidney disease: role of uremic toxins","volume":"18","author":"Koppe","year":"2018","journal-title":"Curr. Diab. Rep."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3390\/biology10040322","article-title":"Multi-strain probiotics: synergy among isolates enhances biological activities","volume":"10","author":"Kwoji","year":"2021","journal-title":"Biology (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1136\/gutjnl-2024-334634","article-title":"Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-microbiome study","volume":"74","author":"Laiola","year":"2025","journal-title":"Gut"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s00018-024-05532-5","article-title":"Gut microbiota regulates oxidative stress and inflammation: a double-edged sword in renal fibrosis","volume":"81","author":"Li","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1210\/endrev\/bnz010","article-title":"The new biology of diabetic kidney disease-mechanisms and therapeutic implications","volume":"41","author":"Lytvyn","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.1039\/c8fo00888d","article-title":"Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial","volume":"9","author":"Mafi","year":"2018","journal-title":"Food Funct."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.3390\/nu13103637","article-title":"A link between chronic kidney disease and gut microbiota in immunological and nutritional aspects","volume":"13","author":"Mertowska","year":"2021","journal-title":"Nutrients"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12602-017-9325-3","article-title":"Probiotic soy Milk consumption and renal function among type 2 diabetic patients with nephropathy: a randomized controlled clinical trial","volume":"11","author":"Miraghajani","year":"2019","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"101484","DOI":"10.1016\/j.beem.2021.101484","article-title":"Intestinal microbiota and diabetic kidney diseases: the role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression","volume":"35","author":"Mosterd","year":"2021","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.13193\/j.issn.1673-7717.2013.09.141","article-title":"Clinical observation of Cordyceps sinensis Cs-4 mycelium powder as an adjuvant therapy for diabetic nephropathy","volume":"31","author":"Ni","year":"2013","journal-title":"J. Tradit. Chin. Med."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"106520","DOI":"10.1016\/j.phrs.2022.106520","article-title":"The effect of microbiome-modulating probiotics, prebiotics and synbiotics on glucose homeostasis in type 2 diabetes: a systematic review, meta-analysis, and meta-regression of clinical trials","volume":"185","author":"Paul","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e74621","DOI":"10.7759\/cureus.74621","article-title":"A randomized double-blind placebo-controlled study on the safety and efficacy of probiotics for insulin resistance and oxidative stress markers in diabetic patients with end-stage renal disease on hemodialysis","volume":"16","author":"Pingali","year":"2024","journal-title":"Cureus"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e2201581","DOI":"10.1002\/advs.202201581","article-title":"Gut microbiome analysis can be used as a noninvasive diagnostic tool and plays an essential role in the onset of membranous nephropathy","volume":"9","author":"Shang","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"ref34","first-page":"1112","article-title":"Effects of microecological agents on gut microbiota in community patients with diabetic kidney disease","volume":"26","author":"Sheng","year":"2023","journal-title":"Chin. Gen. Pract."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.kint.2016.09.040","article-title":"Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects","volume":"91","author":"Soleimani","year":"2017","journal-title":"Kidney Int."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"20801","DOI":"10.1021\/acs.jafc.3c04665","article-title":"Amelioration of type 2 diabetes using four strains of Lactobacillus probiotics: effects on gut microbiota reconstitution-mediated regulation of glucose homeostasis, inflammation, and oxidative stress in mice","volume":"71","author":"Song","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"98719","DOI":"10.5527\/wjn.v13.i4.98719","article-title":"Probiotic interventions in peritoneal dialysis: a review of underlying mechanisms and therapeutic potentials","volume":"13","author":"Stepanova","year":"2024","journal-title":"World J Nephrol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12967-022-03585-3","article-title":"Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling","volume":"20","author":"Tan","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"570","DOI":"10.13381\/j.cnki.cjm.202005016","article-title":"Effects of probiotic supplementation on disease progression risk in elderly patients with diabetic nephropathy","volume":"32","author":"Tang","year":"2020","journal-title":"Chin. J. Microecol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1526690","DOI":"10.3389\/fmicb.2025.1526690","article-title":"Clinical efficacy of probiotic supplementation in the treatment of knee osteoarthritis: a meta-analysis","volume":"16","author":"Tian","year":"2025","journal-title":"Front. Microbiol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","article-title":"Molecular mechanisms and therapeutic targets for diabetic kidney disease","volume":"102","author":"Tuttle","year":"2022","journal-title":"Kidney Int."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","article-title":"Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences","volume":"290","author":"Vaziri","year":"2006","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e651","DOI":"10.1002\/mco2.651","article-title":"Endothelial dysfunction: molecular mechanisms and clinical implications","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm (2020)"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","article-title":"Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000360010","article-title":"Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD","volume":"39","author":"Wong","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"ref46","first-page":"36","article-title":"Effects of probiotic supplementation on nutrient intake, ghrelin, and adiponectin concentrations in diabetic hemodialysis patients","volume":"29","author":"Zhang","year":"2023","journal-title":"Altern. Ther. Health Med."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.kint.2024.12.021","article-title":"The prevention and management of chronic kidney disease among patients with metabolic syndrome","volume":"107","author":"Zhu","year":"2025","journal-title":"Kidney Int."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1760954\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:46:00Z","timestamp":1779255960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1760954\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":47,"alternative-id":["10.3389\/fmicb.2026.1760954"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1760954","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"article-number":"1760954"}}